World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
31234
World Ranking
13072
National Ranking
6674

Overview

Alexa B. Kimball is affiliated with Beth Israel Deaconess Medical Center in the United States with a research focus in medicine, particularly dermatology. Their work spans several subfields including surgery, epidemiology, immunology, and public health, environmental and occupational health. The primary emphasis of their research lies in the study of skin-related diseases and treatments.

The scientist's research covers a range of main topics, prominently featuring hidradenitis suppurativa and its treatments. Other key topics include colorectal and anal carcinomas, chemotherapy-related skin toxicity, microscopic colitis, dermatology and skin diseases in general, psoriasis focusing on treatment and pathogenesis, and anorectal disease treatments and outcomes.

Some of Alexa B. Kimball's recent papers include:

  • Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials, 2023, The Lancet
  • Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations, 2021, Journal of the American Academy of Dermatology
  • Impact of Endometriosis on Life-Course Potential: A Narrative Review, 2021, International Journal of General Medicine
  • Hidradenitis suppurativa, 2020, Nature Reviews Disease Primers
  • What causes hidradenitis suppurativa?-15 years after, 2020, Experimental Dermatology

Alexa B. Kimball has collaborated frequently with several researchers, including Martina L. Porter, Afsáneh Alavi, Errol P. Prens, Falk G. Bechara, and Shoba Ravichandran. These partnerships have contributed to a substantial body of work in the dermatological sciences.

The most common venues for publishing their research include:

  • Journal of the American Academy of Dermatology
  • Journal of Investigative Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • British Journal of Dermatology
  • International Journal of Women's Dermatology

Best Publications

  • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

    Craig L Leonardi;Alexa B Kimball;Kim A Papp;Newman Yeilding

  • Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    Alan Menter;Stephen K. Tyring;Kenneth Gordon;Alexa B. Kimball

  • IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

    Jason R. Chan;Wendy Blumenschein;Erin Murphy;Caroline Diveu

  • Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    Mark Lebwohl;Bruce Strober;Alan Menter;Kenneth Gordon

  • Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

    Andrew Blauvelt;Kim A. Papp;Christopher E.M. Griffiths;Bruce Randazzo;Bruce Randazzo

  • Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

    Alexa B Kimball;Martin M Okun;David A Williams;Alice B Gottlieb

  • The psychosocial burden of psoriasis.

    Alexa B Kimball;Christine Jacobson;Stefan Weiss;Mary G Vreeland

  • Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

    Kristian Reich;Kim A Papp;Andrew Blauvelt;Stephen K Tyring

  • National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

    Alexa B. Kimball;Dafna Gladman;Joel M. Gelfand;Kenneth Gordon

  • Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Parallel Randomized Trial

    Alexa B. Kimball;Francisco Kerdel;David Adams;Ulrich Mrowietz

  • Quantifying the harmful effect of psoriasis on health-related quality of life.

    Stefan C. Weiss;Alexa B. Kimball;David J. Liewehr;Andrew Blauvelt

  • Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events: A Meta-analysis of Randomized Controlled Trials

    Caitriona Ryan;Craig L. Leonardi;James G. Krueger;Alexa B. Kimball

  • Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies

    P.L. Mattei;K.C. Corey;A.B. Kimball

  • North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

    Ali Alikhan;Christopher Sayed;Afsaneh Alavi;Raed Alhusayen

  • The US dermatology workforce: A specialty remains in shortage

    Alexa Boer Kimball;Jack S. Resneck

  • North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management

    Ali Alikhan;Christopher Sayed;Afsaneh Alavi;Raed Alhusayen

  • Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis : Results of a Randomized, Placebo-Controlled, Phase 2 Trial

    Alexa B. Kimball;Kenneth B. Gordon;Richard G. Langley;Alan Menter

  • The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress.

    Annie Chiu;Susan Y. Chon;Alexa B. Kimball

  • Psoriasis: is the impairment to a patient's life cumulative?

    AB Kimball;U Gieler;D Linder;F Sampogna

  • Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

    Alexa B. Kimball;Francisco Kerdel;David Adams;Ulrich Mrowietz

Frequent Co-Authors

Kenneth B. Gordon
Kenneth B. Gordon Medical College of Wisconsin
Kim Papp
Kim Papp Probity Medical Research
Andrew Blauvelt
Andrew Blauvelt Veterans Health Administration
Richard G. Langley
Richard G. Langley Dalhousie University
Gregor B. E. Jemec
Gregor B. E. Jemec University of Copenhagen
Joel M. Gelfand
Joel M. Gelfand University of Pennsylvania
Kristian Reich
Kristian Reich University of Göttingen
Alan Menter
Alan Menter Texas A&M University
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Craig L. Leonardi
Craig L. Leonardi Saint Louis University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in Medicine but seeking flexible options, there are several online degrees that can broaden your healthcare career pathway. Many students explore the cheapest mha programs online healthcare for an affordable route to leadership roles in hospital administration or healthcare organizations.

Nursing professionals who want to advance their clinical expertise might choose one of the best online bsn to dnp programs. These Doctor of Nursing Practice programs often offer flexible formats for registered nurses moving into higher-level practice or administrative positions.

For those interested in pharmacy, the 3 year online pharmd options provide a faster, more convenient pathway to becoming a pharmacist, especially for working professionals balancing education and career.

Lastly, the demand for health data specialists is growing. Students can enroll in online schools for health information management to prepare for roles in healthcare IT and patient data management.

Each of these accredited online programs can open doors to specialized healthcare roles—helping you build a rewarding healthcare career, even if you decide not to pursue a traditional MD degree.

Best Scientists Citing Alexa B. Kimball

Trending Scientists